4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001649904-26-000007
EVP, Head of International sold 57,000 shares at an average $116.15 ($6,620,575)
- EVP, Head of International acquired 46,625 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mazabraud Yann EVP, Head of International | 2026-08-12 | Option exercise 10b5-1 | +46,625 | $6.80 | $317,050 | 112,655 | D |
| Mazabraud Yann EVP, Head of International | 2026-08-12 | Sale 10b5-1 | −2,300 | $111.80 | $257,138 | 110,355 | D |
| Mazabraud Yann EVP, Head of International | 2026-08-12 | Sale 10b5-1 | −1,000 | $112.86 | $112,856 | 109,355 | D |
| Mazabraud Yann EVP, Head of International | 2026-08-12 | Sale 10b5-1 | −3,605 | $114.70 | $413,477 | 105,750 | D |
| Mazabraud Yann EVP, Head of International | 2026-08-12 | Sale 10b5-1 | −14,568 | $115.43 | $1,681,541 | 91,182 | D |
| Mazabraud Yann EVP, Head of International | 2026-08-12 | Sale 10b5-1 | −18,208 | $116.49 | $2,121,125 | 72,974 | D |
| Mazabraud Yann EVP, Head of International | 2026-08-12 | Sale 10b5-1 | −17,319 | $117.47 | $2,034,439 | 55,655 | D |
| Derivatives | |||||||
| Mazabraud Yann EVP, Head of International | 2026-08-12 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −46,625 | 35,875 | D | ||
| Open-market sales · 57,000 sh · avg $116.15 · $6,620,575 | |||||||
Loading xslF345X06/form4.xml…